×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Haemonetics Corporation Completes Acquisition of OpSens Inc.
PR Newswire
Share this article ... BOSTON, Dec. ... Haemonetics acquired all outstanding shares of OpSens for CAD $2.90 per share in the all-cash transaction,...
5 months ago
Opsens (OTCMKTS:OPSSF) Stock Price Passes Below Two Hundred Day Moving Average of $2.13
Defense World
Opsens Inc. (OTCMKTS:OPSSF – Get Free Report) shares passed below its 200-day moving average during trading on Friday .
2 days ago
Haemonetics (HAE) Announces Agreement to Acquire OpSens
Yahoo
Haemonetics' (HAE) acquisition of OpSens will expand its leadership in the interventional cardiology market.
4 days ago
Haemonetics completes $255M OpSens acquisition
MassDevice
Haemonetics announced today that it completed its previously announced acquisition of cardiology-focused medical device company OpSens.
5 months ago
Haemonetics Corp. to Buy OpSens, Inc.
Optics & Photonics News
The US-based global medical technology firm Haemonetics Corporation announced that it has entered into a definitive agreement to acquire the...
7 months ago
HAEMONETICS COMPLETES ACQUISITION OF OPSENS Français
Canada Newswire
As a result of the completion of the Arrangement, it is expected that trading of the Shares will cease in the public market, and the Shares will...
5 months ago
Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.
PR Newswire
BOSTON, Oct. 10, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative...
7 months ago
Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD
BetaKit
Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD. OpSens said acquisition will provide the...
7 months ago
Haemonetics offers $253M for TAVR guidewire maker OpSens
Fierce Biotech
The Boston-based devicemaker announced Tuesday that it plans to acquire OpSens, the Canadian developer of a range of optical sensor-equipped...
7 months ago
Haemonetics Set to Acquire OpSens
Medical Device and Diagnostic industry
Haemonetics will acquire the company by buying all outstanding shares for CAD $2.90 per share in an all-cash transaction “representing a fully...
7 months ago